-The Hindu They are protesting salary deduction   Malaria and TB treatment is seriously affected in Manipur following a strike by contractual employees. The worst hit are the Directly Observed Treatment Short Course, the Revised National Tuberculosis Control Programme (RNTCP) and sputum microscopy programmes. T. Lenindro, general secretary of the All Manipur RNTCP Contractual Workers’ Welfare Union, toldThe Hindu that though the contractual appointment of 116 employees of the RNTCP from March 2012 to...

-Live Mint State’s role to diminish from that of provider to manager, making way for private companies, individual practitioners The government is set to relinquish its role as a provider of primary healthcare, making way for private companies and individual medical practitioners to take the lead in offering clinical services, and focus on preventive interventions such as immunization and HIV testing. The move is in line with the government’s approach of outsourcing its...

-The Indian Express In Raipur hospitals, a joke doing the rounds these days is: “Soon, someone will file an RTI to know the number of uteruses left in Chhattisgarh.” What has prompted it is, however, no joke. If a series of media reports in the state is to be believed, the uteruses of thousands of women have been removed in unnecessary operations. These reports talk of doctors cheating BPL families by encouraging...

-The Hindu The Indian Radiological and Imaging Association (IRIA) has called the recent order of the Union Health & Family Welfare Ministry restricting radiologists/sonologists from visiting more than two clinics within a district to perform ultrasound tests and making it mandatory to specify their consulting hours at each clinic as “unconstitutional, undemocratic and ill-thought”. At a Press conference here on Thursday, IRIA president Harsh Mahajan said: “This latest order will create a...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...